Phoenix Biotech Acquisition Corp - Units (1 Ord Class A

(Units)
NAS:PBAXU (USA)   Units (1 Ord Class A & 1/2 War)
$ 10.37 0 (0%) 12:09 AM EST
At Loss
Volume:
-
Avg Vol (2M):
-

Business Description

Phoenix Biotech Acquisition Corp
NAICS : 551112 SIC : 6719
ISIN : US71902K2042

Share Class Description:

PBAXU: Units (1 Ord Class A & 1/2 War)
Compare
Compare
NVACGMFIFHLTASPAMAQCEFHTMACABWAQFORLKYCHPBAJSVMBSCRMCVIIAACGHIXALCCAACTDWACSAGA
Traded in other countries / regions
IPO Date
2021-10-06
Description
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe.
Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset -0.65
Debt-to-Equity -0.26
Debt-to-EBITDA -0.36
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.17
9-Day RSI 40.16
14-Day RSI 41.71
6-1 Month Momentum % -3.71
12-1 Month Momentum % -2.17

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.76
Quick Ratio 1.76
Cash Ratio 0.02

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -7.41
ROA % -4.84
ROIC % -10.3
ROC (Joel Greenblatt) % -39.38
ROCE % -8.93

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -9.8
EV-to-EBITDA -9.8
EV-to-FCF -22.07
Earnings Yield (Greenblatt) % -10.2
FCF Yield % -4.69

Financials (Next Earnings Date:2025-05-10 Est.)

PBAXU's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PBAXU

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Phoenix Biotech Acquisition Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0
Beta 0
Volatility % 18.73
14-Day RSI 41.71
14-Day ATR ($) 0.112913
20-Day SMA ($) 10.4905
12-1 Month Momentum % -2.17
52-Week Range ($) 9.82 - 11.73
Shares Outstanding (Mil)

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Phoenix Biotech Acquisition Corp Filings

Filing Date Document Date Form
No Filing Data

Phoenix Biotech Acquisition Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Phoenix Biotech Acquisition Corp Frequently Asked Questions

What is Phoenix Biotech Acquisition Corp(PBAXU)'s stock price today?
The current price of PBAXU is $10.37. The 52 week high of PBAXU is $11.73 and 52 week low is $9.82.
When is next earnings date of Phoenix Biotech Acquisition Corp(PBAXU)?
The next earnings date of Phoenix Biotech Acquisition Corp(PBAXU) is 2025-05-10 Est..
Does Phoenix Biotech Acquisition Corp(PBAXU) pay dividends? If so, how much?
Phoenix Biotech Acquisition Corp(PBAXU) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1